<!DOCTYPE html><html lang="en"><head><title>Static News</title><meta charSet="utf-8"/><meta name="description" content="Static delayed Hacker News."/><meta name="theme-color" media="(prefers-color-scheme: light)" content="white"/><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1d1f21"/><meta name="viewport" content="width=device-width,initial-scale=1.0"/><meta name="application-name" content="Static News"/><meta name="apple-mobile-web-app-title" content="Static News"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="#1d1f21"/><link rel="preload" href="styles.css?v=1708160453223" as="style"/><link rel="stylesheet" href="styles.css?v=1708160453223"/></head><body><div id="container"><div id="inner"><header><a href="/">Static News</a><a href="/about">about</a></header><div id="content"><div><div id="title"><a href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-treat-severe-frostbite">FDA Approves First Medication to Treat Severe Frostbite</a>Â <span class="domain">(<a href="https://www.fda.gov">www.fda.gov</a>)</span></div><div class="subtext"><span>jyunwai</span> | <span>9 comments</span></div><br/><div><div id="39406806" class="c"><input type="checkbox" id="c-39406806" checked=""/><div class="controls bullet"><span class="by">yellow_lead</span><span>|</span><a href="#39407297">next</a><span>|</span><label class="collapse" for="c-39406806">[-]</label><label class="expand" for="c-39406806">[3 more]</label></div><br/><div class="children"><div class="content">&gt; One of these groups (Group 1) received iloprost by vein (intravenously) for 6 hours daily for up to 8 days. The two other groups received other medications that are unapproved for frostbite, given with iloprost (Group 2) or without iloprost (Group 3).<p>&gt; On day 7, the bone scan finding predictive of needing amputation was observed in 0% (0 of 16) patients receiving iloprost alone (Group 1) compared to 19% (3 of 16) patients in Group 2 and 60% (9 of 15) patients in Group 3. The presence of the bone scan abnormality was significantly lower in the two groups receiving iloprost. Most patients had follow-up information on whether they subsequently underwent at least one finger or toe amputation. The need for amputation was consistent with the bone scan findings.<p>It seems like an effective drug based on this result.</div><br/><div id="39407253" class="c"><input type="checkbox" id="c-39407253" checked=""/><div class="controls bullet"><span class="by">sidkshatriya</span><span>|</span><a href="#39406806">parent</a><span>|</span><a href="#39407026">next</a><span>|</span><label class="collapse" for="c-39407253">[-]</label><label class="expand" for="c-39407253">[1 more]</label></div><br/><div class="children"><div class="content">&gt; On day 7, the bone scan finding predictive of needing amputation was observed in 0% (0 of 16) patients receiving iloprost alone (Group 1) compared to 19% (3 of 16) patients in Group 2 and 60% (9 of 15) patients in Group 3.<p>Ah ! It would have sucked to have Frostbite not be in Group 1 and then need to undergo amputation. Talk about bad luck ! However, I totally understand that this is the main way for the science to progress and treatments to get validated.</div><br/></div></div><div id="39407026" class="c"><input type="checkbox" id="c-39407026" checked=""/><div class="controls bullet"><span class="by">fs_tab</span><span>|</span><a href="#39406806">parent</a><span>|</span><a href="#39407253">prev</a><span>|</span><a href="#39407297">next</a><span>|</span><label class="collapse" for="c-39407026">[-]</label><label class="expand" for="c-39407026">[1 more]</label></div><br/><div class="children"><div class="content">Does anyone on here know if this is due to the fact that it&#x27;s a general vasodilator, or if there are specific pathways (eg: from activating prostacyclin and prostaglandin receptors) which have the effect of reducing tissue&#x2F;bone damage?</div><br/></div></div></div></div><div id="39407297" class="c"><input type="checkbox" id="c-39407297" checked=""/><div class="controls bullet"><span class="by">tommiegannert</span><span>|</span><a href="#39406806">prev</a><span>|</span><a href="#39406573">next</a><span>|</span><label class="collapse" for="c-39407297">[-]</label><label class="expand" for="c-39407297">[1 more]</label></div><br/><div class="children"><div class="content">Seems the news here is just the study and approval for frostbite; nothing special about how it works?<p>&gt; Iloprost is a medication used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud&#x27;s phenomenon, frostbite, and other conditionss in which the blood vessels are constricted and blood cannot flow to the tissues. This damages the tissues and causes high blood pressure. Iloprost works by opening (dilating) the blood vessels to allow the blood to flow through again.<p><a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Iloprost" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Iloprost</a></div><br/></div></div><div id="39406573" class="c"><input type="checkbox" id="c-39406573" checked=""/><div class="controls bullet"><span class="by">Vecr</span><span>|</span><a href="#39407297">prev</a><span>|</span><label class="collapse" for="c-39406573">[-]</label><label class="expand" for="c-39406573">[4 more]</label></div><br/><div class="children"><div class="content">Interesting, however<p>&gt; to reduce the risk of finger or toe amputation<p>is not how risk works, similar to a basic conditionalization that tells you not to go to the doctor for an illness as that action would provide evidence for an increased probability of death.</div><br/><div id="39406809" class="c"><input type="checkbox" id="c-39406809" checked=""/><div class="controls bullet"><span class="by">Aurornis</span><span>|</span><a href="#39406573">parent</a><span>|</span><label class="collapse" for="c-39406809">[-]</label><label class="expand" for="c-39406809">[3 more]</label></div><br/><div class="children"><div class="content">&gt; is not how risk works, similar to a basic conditionalization that tells you not to go to the doctor for an illness as that action would provide evidence for an increased probability of death.<p>I don&#x27;t know what you&#x27;re saying here, but this medication is an injection that is given to someone by doctors after they&#x27;ve sought emergency medical treatment.<p>The article was trying to communicate that it increases the odds of being able to keep the appendage. Debating the wording is rather pedantic.</div><br/><div id="39406857" class="c"><input type="checkbox" id="c-39406857" checked=""/><div class="controls bullet"><span class="by">Vecr</span><span>|</span><a href="#39406573">root</a><span>|</span><a href="#39406809">parent</a><span>|</span><label class="collapse" for="c-39406857">[-]</label><label class="expand" for="c-39406857">[2 more]</label></div><br/><div class="children"><div class="content">Assuming you&#x27;re fine with (somewhat debatable) casual language, &quot;this drug (probably) causes probabilistic physical events leading to a lower chance of medically determined necessity to amputate, conditional on the correct medical examination being done at the right times&quot;.</div><br/><div id="39407130" class="c"><input type="checkbox" id="c-39407130" checked=""/><div class="controls bullet"><span class="by">Intermernet</span><span>|</span><a href="#39406573">root</a><span>|</span><a href="#39406857">parent</a><span>|</span><label class="collapse" for="c-39407130">[-]</label><label class="expand" for="c-39407130">[1 more]</label></div><br/><div class="children"><div class="content">This is analogous to how much medical research is done. Unless you want to go the literal Nazi method of inducing illness or incapacity and then testing remedies, this is sort of the best we have. Final stage medical research involves humans to test on. Preferably voluntarily, and preferably when they require the treatment through actual misfortune
.</div><br/></div></div></div></div></div></div></div></div></div></div></div></div></div></body></html>